Analyst Reco. ResMed, Inc.

Equities

RMD

US7611521078

Market Closed - Nyse Other stock markets 01:30:01 14/09/2024 am IST			5-day change	1st Jan Change
248.93 ^USD	-0.71%		+1.66%	+44.71%

13/09	Resmed Insider Sold Shares Worth $1,262,800, According to a Recent SEC Filing	MT
11/09	ResMed Insider Sold Shares Worth $3,646,950, According to a Recent SEC Filing	MT

Analyst Reco.

Unlock all the news: Be the first to know and act before the market!

100% Free Registration

Needham Downgrades ResMed to Hold From Buy	04/09	MT
UBS Adjusts Price Target on ResMed to $225 From $210, Maintains Neutral Rating	05/08	MT
RBC Adjusts ResMed's Price Target to $206 From $204, Keeps Sector Perform Rating	02/08	MT
Mizuho Securities Adjusts ResMed Price Target to $230 From $220	02/08	MT
KeyBanc Adjusts Price Target on ResMed to $251 From $238	02/08	MT
Jefferies Adjusts Price Target on ResMed to $200 From $180	02/08	MT
JPMorgan Adjusts Price Target on ResMed to $240 From $225, Maintains Overweight Rating	02/08	MT
RBC Raises Price Target on ResMed to $204 From $200, Keeps Sector Perform Rating	23/07	MT
UBS Adjusts ResMed Price Target to $210 From $195, Maintains Neutral Rating	19/07	MT
Oppenheimer Downgrades ResMed to Market Perform From Outperform	25/06	MT
Shares of ResMed, Inspire Medical Down After Eli Lilly Provides Sleep Apnea Study Update	24/06	DJ
Resmed Insider Sold Shares Worth $3,107,739, According to a Recent SEC Filing	11/06	MT
Resmed Insider Sold Shares Worth $2,747,810, According to a Recent SEC Filing	11/05	MT
Resmed Insider Sold Shares Worth $3,178,815, According to a Recent SEC Filing	09/05	MT
KeyBanc Adjusts Price Target on ResMed to $238 From $227	26/04	MT
Jefferies Adjusts Price Target on ResMed to $180 From $164	26/04	MT
Oppenheimer Adjusts ResMed Price Target to $200 From $205, Maintains Outperform Rating	26/04	MT
JPMorgan Adjusts Price Target on ResMed to $225 From $198	26/04	MT
Mizuho Adjusts Price Target on ResMed to $220 From $215	26/04	MT
Needham Adjusts Price Target on ResMed to $236 From $224	26/04	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

ResMed, Inc. continues to make headway in the sleep market

December 11, 2023 at 04:25 pm IST